Global Cell Dissociation Market - Segmented by Product, Tissue (Connective Tissue, Epithelial Tissue and Other Tissues), End-User and Geography - Growth, Trends and Forecast (2018 - 2023)
|出版商||Mordor Intelligence LLP||商品編碼||707237|
|出版日期||內容資訊||英文 110 Pages
|全球細胞解離市場:產品，組織(結締組織，表皮組織)，終端用戶，各地區(2018年∼2023年) Global Cell Dissociation Market - Segmented by Product, Tissue (Connective Tissue, Epithelial Tissue and Other Tissues), End-User and Geography - Growth, Trends and Forecast (2018 - 2023)|
|出版日期: 2018年08月01日||內容資訊: 英文 110 Pages||
Cell Dissociation Market Overview
The global cell dissociation market is projected to grow at a CAGR of approximately 12% during the forecast period (2018-2023). Cell dissociation refers to the act of isolating single-cell, usually in a suspension medium from adherent mono-layer of cells for developing differentiated cell lines in-vivo through proliferation or for research of biochemical properties of cell mono-layer itself.
Increasing R&D Activities in Biopharmaceutical Companies
The total worldwide R&D spending of pharmaceutical and biotechnology companies increased from USD 108 billion in 2006 to USD 141 billion in 2015. The high investment in R&D activities of biopharmaceutical companies is indicative of the high return on investment which biopharmaceuticals make upon the commercial release of their pipeline drugs and therapeutics. Increasing prevalence of chronic diseases caused due to lifestyle induced factors have increased the demand for novel therapeutic agents which in turn has directly led to increased spending by biopharmaceutical firms in R&D activities. Cell dissociation is an indispensable activity in biopharmaceutical research as it is involved directly in drug development and pathology elucidation. Consequently, the increased spending by biopharmaceutical companies in R&D activities is driving the growth of global cell dissociation market. Other factor contributing to the growth of global cell dissociation market includes favorable funding of scenario for cancer research.
High Cost of Tissue and Cell Based Procedures
The average cost of functional restoration surgery and soft-tissue reconstruction in US was estimated to be between 9000 to 13,000 USD. The estimated figures for soft-tissue reconstruction is higher for lower- body extremities when compared to upper-body extremities. In addition to this, allografts are often scarce and very low quantities are synthesized in comparison to the economic resources invested in harvesting allografts. Consequently the cost of allografts themselves are subject to price fluctuation depending on their availability. High cost of soft-tissue procedures is therefore limiting the growth of the global cell dissociation market.
North America has the Largest Share in the Cell Dissociation Market
The global cell dissociation market has been segmented into five major regions, viz. North America, Europe, Asia Pacific, Middle East & Africa, and South America. Driven by the developed country of the U.S., North America is dominated the global cell dissociation market in 2017, due to factors such as increased spending by biopharmaceuticals in R&D activities. Furthermore, increasing demand for cancer treatments has prompted the governments in major economies of North America to accelerate the research in oncology, which is in turn is also also boosting the growth of the cell dissociation market in North America.
Non-Enzymatic Dissociation Products Expected to Exhibit Highest Growth
The global cell dissociation market has been segmented on the basis of products into enzymatic dissociation products, non-enzymatic dissociation products, and instruments & accessories. Non-enzymatic dissociation products provide cell samples which are free from protein contamination. Non- enzymatic approaches are easier to employ when compared to enzymatic approaches and also chances of toxicity and contamination are reduced in non-enzymatic cell dissociation. In the current market there is widespread prevalence of enzymatic dissociation products, particularly trypsin. But over the forecast period, non-enzymatic dissociation product category will register fastest growth primarily due to differential advantages it provides over enzyme based dissociation products.
Key Developments in Cell Dissociation Market
Jul 2018: American Type Culture Collection (ATCC), a premier global biological materials resource and standards organization and also the leading supplier of authenticated cells and advanced cell models, announced the commercial availability of its new PCR-based service to detect mycoplasma contamination in cell cultures. This growing service portfolio is part of a larger effort by ATCC to support the authentication of cell lines used in basic and translational research.
Major Players: AMERICAN TYPE CULTURE COLLECTION, BECTON DICKINSON & COMPANY, F. HOFFMANN-LA ROCHE LTD., GE HEALTHCARE, HIMEDIA LABORATORIES, MERCK KGAA, MILTENYI BIOTEC, PAN-BIOTECH, STEMCELL TECHNOLOGIES, and THERMO FISCHER SCIENTIFIC INC. among others.
Reasons to Purchase Cell Dissociation Market Report
Current and future global cell dissociation market outlook in the developed and emerging markets
Analyzing various perspectives of the market with the help of Porter's five forces analysis
The segment that is expected to dominate the market
Regions that are expected to witness fastest growth during the forecast period
Identify the latest developments, market shares and strategies employed by the major market players.
3-month analyst support along with the Market Estimate sheet (in Excel).
Customization of Cell Dissociation Market Report
This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
List Not Exhaustive